Candriam S.C.A.
Institutional investor · Portfolio as of Q3 2019
Top Holdings741 positions
Microsoft Corp | 1.8M | $254.5M | 3.4% | $111.55 | +17.19% | 3 qtrssince 2019-Q1 | Increased 59 |
Amgen Inc | 908,380 | $175.8M | 2.3% | $151.35 | +3.48% | 3 qtrssince 2019-Q1 | Decreased 0 |
Vertex Pharmaceuticals Inc | 930,999 | $157.7M | 2.1% | $183.78 | -7.81% | 3 qtrssince 2019-Q1 | Decreased 0 |
Alphabet Inc | 128,628 | $157.1M | 2.1% | $57.61 | +4.99% | 3 qtrssince 2019-Q1 | Decreased 0 |
Apple Inc | 661,218 | $148.1M | 2.0% | $45.22 | +18.81% | 3 qtrssince 2019-Q1 | Decreased 0 |
Gilead Sciences Inc | 2.2M | $142.4M | 1.9% | $49.21 | -0.58% | 3 qtrssince 2019-Q1 | Increased 54 |
Amazon.com Inc | 79,571 | $138.1M | 1.8% | $89.35 | -2.86% | 3 qtrssince 2019-Q1 | Increased 48 |
Bristol-Myers Squibb Co | 2.6M | $132.9M | 1.8% | $35.87 | +8.30% | 3 qtrssince 2019-Q1 | Increased 51 |
Merck & Co Inc | 1.6M | $132.3M | 1.8% | $63.09 | +2.46% | 3 qtrssince 2019-Q1 | Decreased 0 |
Alibaba Group Holding Ltd | 768,643 | $128.5M | 1.7% | $170.26 | -7.57% | 3 qtrssince 2019-Q1 | Increased 49 |
Regeneron Pharmaceuticals Inc | 412,174 | $114.3M | 1.5% | $389.29 | -29.41% | 3 qtrssince 2019-Q1 | Increased 51 |
Procter & Gamble Co/The | 898,238 | $111.7M | 1.5% | $87.20 | +19.39% | 3 qtrssince 2019-Q1 | Decreased 0 |
Biogen Inc | 438,589 | $102.1M | 1.4% | $236.38 | -1.51% | 3 qtrssince 2019-Q1 | Decreased 0 |
Facebook Inc | 537,263 | $95.7M | 1.3% | $169.08 | +4.32% | 3 qtrssince 2019-Q1 | Decreased 0 |
Illumina Inc | 262,044 | $79.7M | 1.1% | $305.99 | -3.29% | 3 qtrssince 2019-Q1 | Increased 49 |
Cisco Systems Inc/Delaware | 1.5M | $73.3M | 1.0% | $43.00 | -6.24% | 3 qtrssince 2019-Q1 | Increased 50 |
Visa Inc | 391,559 | $67.4M | 0.9% | $148.12 | +10.46% | 3 qtrssince 2019-Q1 | Decreased 0 |
AbbVie Inc | 864,113 | $65.4M | 0.9% | $58.09 | -2.14% | 3 qtrssince 2019-Q1 | Increased 60 |
Walt Disney Co/The | 480,584 | $62.6M | 0.8% | $106.35 | +18.10% | 3 qtrssince 2019-Q1 | Decreased 0 |
Alexion Pharmaceuticals Inc | 631,766 | $61.9M | 0.8% | — | — | 3 qtrssince 2019-Q1 | Increased 46 |
Candriam S.C.A. manages $7.5B across 741 positions as of Q3 2019. Top holdings: MSFT (3.4%), AMGN (2.3%), VRTX (2.1%). Fund DNA: Steady Compounder. HoldingsIntel Score: 2.5/5.0.
Active quarter - 67 new positions, 131 exits, 357 increased. Top move: ABBV (INCREASED, conviction 60). Portfolio: $7.5B across 741 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR